First Time Loading...

Arix Bioscience PLC
LSE:ARIX

Watchlist Manager
Arix Bioscience PLC Logo
Arix Bioscience PLC
LSE:ARIX
Watchlist
Price: 142 GBX Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

77k
-31%
Revenue
Jun 30, 2023 77k
Dec 31, 2022 112k
Jun 30, 2022 219k
Dec 31, 2021 340k
-6m
-14%
Operating Income
Jun 30, 2023 -6m
Dec 31, 2022 -5.3m
Jun 30, 2022 -4.6m
Dec 31, 2021 -4.7m
15m
Net Income
Jun 30, 2023 15m
Dec 31, 2022 -27.6m
Jun 30, 2022 -52.7m
Dec 31, 2021 -61.1m

Earnings Waterfall
Arix Bioscience PLC

Revenue
77k GBP
Operating Expenses
-6.1m GBP
Operating Income
-6m GBP
Other Expenses
21m GBP
Net Income
15m GBP

Income Statement
Arix Bioscience PLC

Rotate your device to view
Income Statement
Currency: GBP
Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023
Revenue
Revenue
0
N/A
0
-27%
0
-36%
0
-49%
0
-31%
Operating Income
Operating Expenses
(6)
(5)
(5)
(5)
(6)
Selling, General & Administrative
(6)
(5)
(5)
(5)
(6)
Operating Income
(6)
N/A
(5)
+21%
(5)
+2%
(5)
-14%
(6)
-14%
Pre-Tax Income
Interest Income Expense
46
(49)
(39)
(22)
20
Non-Reccuring Items
(1)
(7)
(9)
0
1
Total Other Income
(0)
0
(0)
0
0
Pre-Tax Income
39
N/A
(61)
N/A
(53)
+14%
(28)
+48%
15
N/A
Net Income
Tax Provision
0
0
(0)
0
0
Income from Continuing Operations
39
(61)
(53)
(28)
15
Net Income (Common)
39
N/A
(61)
N/A
(53)
+14%
(28)
+48%
15
N/A
EPS (Diluted)
0.3
N/A
-0.48
N/A
-0.42
+13%
-0.22
+48%
0.12
N/A

See Also

Summary
ARIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARIX stock valuation using valuation multiples.
Wall Street Estimates
ARIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.